Shanghai, China

Li Mao

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Li Mao: A Pioneer in Cancer Treatment

Introduction

Li Mao, an influential inventor based in Shanghai, China, has made significant contributions to the field of cancer treatment through his innovative patents. With a total of five patents to his name, Mao focuses on developing advanced therapies that harness the power of modified T cells to combat solid tumors.

Latest Patents

One of Li Mao's latest patents is centered around the concept of chimeric antigen receptor (CAR) cells for treating solid tumors. The techniques described in this patent involve CAR therapies that utilize compositions comprising an extracellular domain capable of binding to either a siglec protein or a receptor associated with the peptide hormone kisspeptin. This innovation aims to improve patient outcomes in the notoriously challenging area of solid tumor treatment.

Additionally, Mao's work on chimeric antigen receptor and T cell receptor (TCR) modified T cells presents promising methods for cancer treatment. This patent describes the use of modified T cells where TRAC genes are inactivated via a Zinc-finger nuclease (ZFN). The ZFN employed in this method consists of a first zinc finger protein that targets a specific site in the T-cell receptor alpha constant (TRAC) gene, thereby creating a specialized T cell receptor for fighting cancer.

Career Highlights

Throughout his career, Li Mao has made remarkable strides in the field of cellular therapeutics. He has worked with leading companies such as Innovative Cellular Therapeutics Holdings, Ltd. and Innovative Cellular Therapeutics, Inc. These companies focus on developing cutting-edge treatments that push the boundaries of traditional cancer therapies.

Collaborations

Mao has also collaborated with esteemed professionals in his field, including Lei Xiao and Zhao Wu, both of whom have contributed to the advancement of cancer treatment modalities. These partnerships have fostered an environment of innovation and paved the way for groundbreaking discoveries.

Conclusion

Li Mao's contributions to the realm of cancer treatment exemplify the essence of innovation in science and technology. With his expertise in developing advanced therapeutic techniques like CAR and TCR modified T cells, Mao stands as a beacon of hope for many battling cancer. His passion for research and collaboration continues to inspire future generations of inventors and scientists in the pursuit of innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…